Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Estrogen Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01791478
What this trial is testing

BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerHER2-negative Breast CancerInvasive Ductal Breast Carcinoma+3 more
Vanderbilt-Ingram Cancer Center 46
Early research (Phase 1)Ended earlyNCT02476955
What this trial is testing

Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole

Who this might be right for
Solid TumorsOvarian CancerEndometrial Cancer
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 41
Large-scale testing (Phase 3)Study completedNCT00022516
What this trial is testing

Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 1,086
Large-scale testing (Phase 3)Study completedNCT00522873
What this trial is testing

Endometrial Safety Study

Who this might be right for
Postmenopause
Bayer 662
Testing effectiveness (Phase 2)Study completedNCT00049062
What this trial is testing

Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
The University of Texas Health Science Center at San Antonio
Testing effectiveness (Phase 2)Study completedNCT01234857
What this trial is testing

Ridaforolimus (MK-8669) in Combination With Dalotuzumab (MK-0646) Compared to Standard of Care Treatment in Estrogen Receptor Positive Breast Cancer Patients (MK-8669-041 AM3)

Who this might be right for
Breast Cancer
Merck Sharp & Dohme LLC 115
Large-scale testing (Phase 3)Ended earlyNCT00968968
What this trial is testing

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

Who this might be right for
Cancer
Novartis Pharmaceuticals 37
Testing effectiveness (Phase 2)Study completedNCT00018343
What this trial is testing

Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen

Who this might be right for
Alzheimer's Disease
US Department of Veterans Affairs
Testing effectiveness (Phase 2)Ended earlyNCT03519178
What this trial is testing

PF-06873600 in People With Cancer

Who this might be right for
HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer
Pfizer 155
Testing effectiveness (Phase 2)Study completedNCT00194779
What this trial is testing

Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery

Who this might be right for
Estrogen Receptor-negative Breast CancerEstrogen Receptor-positive Breast CancerHER2-positive Breast Cancer+6 more
University of Washington 50
Testing effectiveness (Phase 2)Study completedNCT00044876
What this trial is testing

Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist

Who this might be right for
Leiomyoma
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 56
Large-scale testing (Phase 3)Study completedNCT01308814
What this trial is testing

Perimenopausal Estrogen Replacement Therapy Study

Who this might be right for
PerimenopauseMenopauseDepression
University of North Carolina, Chapel Hill 172
Testing effectiveness (Phase 2)Study completedNCT01231659
What this trial is testing

Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Postmenopausal WomenLocally Advanced Metastatic Breast CancerMetastatic Breast Cancer
Novartis Pharmaceuticals 72
Early research (Phase 1)Study completedNCT02349113
What this trial is testing

Effects of Acute Estrogen Therapy on Bone Formation

Who this might be right for
Bone Loss, Age-related
Mayo Clinic 20
Large-scale testing (Phase 3)Study completedNCT03568708
What this trial is testing

Primary Ovarian Insufficiency: Phenotype and Optimal Treatment

Who this might be right for
Primary Ovarian Insufficiency
Children's Hospital Medical Center, Cincinnati 19
Large-scale testing (Phase 3)Study completedNCT00390455
What this trial is testing

Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive

Who this might be right for
Estrogen Receptor PositiveHER2 Positive Breast CarcinomaHER2/Neu Negative+5 more
National Cancer Institute (NCI) 295
Post-approval studies (Phase 4)UnknownNCT03436303
What this trial is testing

The Benefits and Risks of Different Menopausal Hormone Replacement Therapy Regimes in the Treatment of Menopause Syndrome

Who this might be right for
Menopause Syndrome
Peking Union Medical College Hospital 120
Testing effectiveness (Phase 2)Study completedNCT02002403
What this trial is testing

Efficacy and Safety Study to Evaluate Two Doses of Oral DMI-5207 in Adult Subjects With Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Unity Health Toronto 34
Testing effectiveness (Phase 2)Study completedNCT03815929
What this trial is testing

Oophorectomy, Estrogen Therapy and Cardiovascular Disease Risk in Young Women

Who this might be right for
Cardiovascular Risk Reduction
Mayo Clinic 35
Post-approval studies (Phase 4)Looking for participantsNCT06544473
What this trial is testing

Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome

Who this might be right for
Turner SyndromeHypogonadism; OvarianHormone Replacement Therapy+2 more
Aarhus University Hospital 50
Next Page